Heart-Assist Devices

• 

  Subject Areas on Research

  • 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 
  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. 
  • A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. 
  • A Machine Without an Owner's Manual. 
  • A Multicenter Trial of a Shared Decision Support Intervention for Patients and Their Caregivers Offered Destination Therapy for Advanced Heart Failure: DECIDE-LVAD: Rationale, Design, and Pilot Data. 
  • A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective. 
  • A contemporary review of mechanical circulatory support. 
  • A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease. 
  • A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. 
  • A global ranking approach to end points in trials of mechanical circulatory support devices. 
  • A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy. 
  • A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial. 
  • A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices. 
  • A tale of two centrifugal left ventricular assist devices. 
  • A team-based approach to patients in cardiogenic shock. 
  • Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients). 
  • Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. 
  • Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. 
  • Acute kidney injury and 1-year mortality after left ventricular assist device implantation. 
  • Advanced heart failure treated with continuous-flow left ventricular assist device. 
  • Advanced therapies for end-stage heart failure. 
  • Advances in the surgical treatment of heart failure. 
  • Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). 
  • Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: comparing apples and oranges. 
  • After-hour ventricular assist device coverage: what level of expertise is required? 
  • Algorithm for the diagnosis and management of suspected pump thrombus. 
  • Allosensitization in cardiac transplantation: shooting at a moving target. 
  • Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. 
  • Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices. 
  • Antithrombotic Strategies and Device Thrombosis. 
  • Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry. 
  • Aortic Valve Thrombus in a Patient With an Extracorporeal Left Ventricular Assist Device: The Dilemma of Management. 
  • Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. 
  • Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation. 
  • Assessing Frailty in Patients Undergoing Destination Therapy Left Ventricular Assist Device: Observations from Interagency Registry for Mechanically Assisted Circulatory Support. 
  • Associations of Preimplant Red Blood Cell Distribution Width with Clinical Outcomes Among Individuals with Left Ventricular Assist Devices. 
  • BVS5000 support after cardiac transplantation. 
  • Balancing Bleeding and Clotting: The Known Unknowns of Mechanically Assisted Circulation. 
  • Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. 
  • Biventricular Berlin Heart EXCOR pediatric use across the united states. 
  • Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices. 
  • Bleeding and thrombosis associated with ventricular assist device therapy. 
  • Bleeding complications and blood product utilization with left ventricular assist device implantation. 
  • Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. 
  • Bridge to long-term mechanical circulatory support with a left ventricular assist device: novel use of transcatheter aortic valve replacement. 
  • Bridge to transplant with extracorporeal membrane oxygenation followed by HeartWare ventricular assist device in a child. 
  • Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. 
  • Cangrelor use prior to left ventricular assist device surgery: a case series. 
  • Capnocytophagia canimorsus sepsis in an asplenic heart transplant candidate with a left ventricular assist system. 
  • Cardiac Index Declines During Long-Term Left Ventricular Device Support. 
  • Cardiac Rehabilitation After Ventricular Assist Device Implantation: A Worthwhile Exercise? 
  • Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections. 
  • Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention: The DECIDE-LVAD Trial. 
  • Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. 
  • Changes in pulmonary artery pressure before and after left ventricular assist device implantation in patients utilizing remote haemodynamic monitoring. 
  • Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. 
  • Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database. 
  • Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience. 
  • Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. 
  • Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. 
  • Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. 
  • Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures. 
  • Clinical pharmacology considerations for children supported with ventricular assist devices. 
  • Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure. 
  • Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients. 
  • Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow. 
  • Complete LVOT obstruction following aortic valve replacement after HeartMate II implantation. 
  • Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device. 
  • Concomitant Thoracic Aortobifemoral Bypass With Left Ventricular Assist Device Implantation. 
  • Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis. 
  • Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. 
  • Controlling axillary intra-aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one. 
  • Controversies and Challenges of Ventricular Assist Device Therapy. 
  • Cost of ventricular assist devices: can we afford the progress? 
  • Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. 
  • Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic heart transplantation model. 
  • Development of a Pediatric Cardiac Mechanical Support Program. 
  • Device therapy in the management of congestive heart failure. 
  • Different Strokes for Different Folks. 
  • Differential gene expression and genomic patient stratification following left ventricular assist device support. 
  • Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure. 
  • Disparities in access to left ventricular assist device therapy. 
  • Does a pre-left ventricular assist device screening score predict long-term transplantation success? A 2-center analysis. 
  • Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device. 
  • Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. 
  • Durable mechanical circulatory support devices. 
  • Dysphagia in the setting of left ventricular assist device hemolysis. 
  • ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device. 
  • Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study. 
  • Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. 
  • Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography. 
  • Editorial Commentary: Determining the cost-effectiveness of mechanical circulatory support. 
  • Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation. 
  • Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. 
  • Effect of age on outcomes after left ventricular assist device placement. 
  • Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study. 
  • Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. 
  • Effectiveness of an Intervention Supporting Shared Decision Making for Destination Therapy Left Ventricular Assist Device: The DECIDE-LVAD Randomized Clinical Trial. 
  • Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury. 
  • Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices. 
  • Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm. 
  • Enrollment in Heart Failure Clinical Trials: Insights Into Which Entry Criteria Exclude Patients. 
  • Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. 
  • Evaluation of risk indices in continuous-flow left ventricular assist device patients. 
  • Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review. 
  • Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation. 
  • Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. 
  • First successful bridge to cardiac transplantation using direct mechanical ventricular actuation. 
  • Functional status in left ventricular assist device-supported patients: a literature review. 
  • Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. 
  • Glenn shunt facilitated weaning of right ventricular mechanical support. 
  • HVAD: The ENDURANCE Supplemental Trial. 
  • Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. 
  • Heart failure medications prescribed at discharge for patients with left ventricular assist devices. 
  • HeartMate XVE malfunction caused by fluid aspiration into the vent port. 
  • HeartMate® II continuous-flow left ventricular assist system. 
  • Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis. 
  • Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. 
  • Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. 
  • High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry. 
  • Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010. 
  • INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure. 
  • INTERMACS: interval analysis of registry data. 
  • Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. 
  • Identification of Severe Mitral Stenosis Using Real-Time Three-Dimensional Transesophageal Echocardiography During an Left Ventricular Assist Device Insertion. 
  • Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. 
  • Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005. 
  • Impact of left ventricular assist device bridging on posttransplant outcomes. 
  • Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. 
  • Implantable Cardioverter-Defibrillators in Patients With Left Ventricular Assist Devices: On Trial and in Need of a Trial. 
  • Implantable left ventricular assist devices: new hope for patients with end-stage heart failure. 
  • Important role of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock. 
  • Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement. 
  • In vivo testing of a novel blood pump for short-term extracorporeal life support. 
  • Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation. 
  • Incidence, Management, and Outcomes of Trauma in Patients with a Left Ventricular Assist Device in North Carolina. 
  • Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices. 
  • Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. 
  • Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure. 
  • Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation. 
  • Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device. 
  • Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial. 
  • Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels. 
  • Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. 
  • Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry. 
  • Intra-aortic balloon pump trials: questions, answers, and unresolved issues. 
  • Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial. 
  • Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. 
  • Invited commentary. 
  • Is Four Stage Management the Future of Univentricular Hearts? Destination Therapy in the Young. 
  • Is it Time to Get More Aggressive With Aortic Valve Insufficiency During LVAD Implantation? 
  • Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations. 
  • Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. 
  • Left ventricular assist device destination therapy versus extended criteria cardiac transplant. 
  • Left ventricular assist device effects on metabolic substrates in the failing heart. 
  • Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. 
  • Left ventricular assist devices as destination therapy for end-stage heart failure. 
  • Left ventricular assist devices versus medical management in ambulatory heart failure patients: An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study. 
  • Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. 
  • Load-independent analysis of a pulsatile right ventricular assist device. 
  • Long-Term Survival in Patients Receiving a Continuous-Flow Left Ventricular Assist Device. 
  • Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. 
  • Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors. 
  • Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. 
  • Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock. 
  • Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data. 
  • Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures. 
  • Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. 
  • Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. 
  • Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study. 
  • Malpositioned left ventricular assist device cannula: diagnosis and management with transesophageal echocardiography guidance. 
  • Management of Patients With Left Ventricular Assist Devices Requiring Teeth Extraction: Is Halting Anticoagulation Appropriate? 
  • Management of cardiogenic shock. 
  • Management of epistaxis in patients with ventricular assist device: a retrospective review. 
  • Management of pediatric tachyarrhythmias on mechanical support. 
  • Managing VAD Complications: Our Growth Industry. 
  • Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Mechanical Circulatory Support Device Utilization and Heart Transplant Waitlist Outcomes in Patients With Restrictive and Hypertrophic Cardiomyopathy. 
  • Mechanical support as failure intervention in patients with cavopulmonary shunts (MFICS): rationale and aims of a new registry of mechanical circulatory support in single ventricle patients. 
  • Mechanical unloading promotes myocardial energy recovery in human heart failure. 
  • Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease. 
  • Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. 
  • Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist. 
  • Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. 
  • Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery. 
  • Mitral Intervention with LVAD: Preparing for Recovery. 
  • My approach to evaluation of patients prior to high-risk PCI with left ventricular support devices. 
  • Myocardial scar in sarcoidosis by 12-lead ECG and pathology. 
  • Myocardial tolerance to mechanical actuation is affected by biomaterial characteristics. 
  • Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. 
  • Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices. 
  • Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. 
  • Nonpharmacologic therapy in heart failure: an overview. 
  • Novel approaches to clinical trials: device-related infections. 
  • One-and-done: Do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? 
  • Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis? 
  • Optimism, Pessimism, and Pragmatism: Musings on the Cost of Medical Innovation. 
  • Orthostatic Hypotension in Patients With Left Ventricular Assist Devices: Acquired Autonomic Dysfunction. 
  • Outcomes After Extracorporeal Right Ventricular Assist Device Combined With Durable Left Ventricular Assist Device Support. 
  • Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. 
  • Outcomes after implantable left ventricular assist device replacement procedures. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation. 
  • Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. 
  • Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device. 
  • Outcomes of Laparoscopic Cholecystectomy in Patients Supported with a Left Ventricular Assist Device. 
  • Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. 
  • Overview of the US FDA medical device approval process. 
  • PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. 
  • PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study. 
  • Paediatric cardiomyopathy and anaesthesia. 
  • Part II: Sealing holes in the safety net. 
  • Patient selection for left ventricular assist devices. 
  • Patient selection for mechanical circulatory support. 
  • Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management). 
  • Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock. 
  • Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. 
  • Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. 
  • Performance of currently available risk models in a cohort of mechanically supported high-risk percutaneous coronary intervention--From the PROTECT II randomized trial. 
  • Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. 
  • Physiological and Psychological Stress in Patients Living With a Left Ventricular Assist Device. 
  • Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients. 
  • Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support. 
  • Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation. 
  • Point-of-Care Rapid-Seeding Ventricular Assist Device with Blood-Derived Endothelial Cells to Create a Living Antithrombotic Coating. 
  • Positive Impact of Continuous-Flow Left Ventricular Assist Device Implantation on Glycemic Control in Patients with Type 2 Diabetes Mellitus and Advanced Chronic Systolic Heart Failure. 
  • Post-Myocardial Infarction Heart Failure. 
  • Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. 
  • Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. 
  • Pre-operative proteinuria in left ventricular assist devices and clinical outcome. 
  • Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. 
  • Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. 
  • Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. 
  • Preparedness planning before mechanical circulatory support: a "how-to" guide for palliative medicine clinicians. 
  • Presentation and management of left ventricular assist device inflow cannula malposition. 
  • Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients With Advanced Heart Failure: Insights From the ESCAPE Trial. 
  • Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support. 
  • Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. 
  • Prolonged total circulatory support using direct mechanical ventricular actuation. 
  • Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. 
  • Pump speed modulations and sub-maximal exercise tolerance in left ventricular assist device recipients: A double-blind, randomized trial. 
  • Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry. 
  • Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. 
  • Ramp Study Hemodynamics, Functional Capacity, and Outcome in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices. 
  • Ramping up evidence-based ventricular assist device care. 
  • Re: Desmopressin Use in Refractory Gastrointestinal Bleeding in LVAD Patient. 
  • Recommendations on the Indications for RBC Transfusion for the Critically Ill Child Receiving Support From Extracorporeal Membrane Oxygenation, Ventricular Assist, and Renal Replacement Therapy Devices From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative. 
  • Recurrence of cardiac sarcoidosis in a heart transplant recipient. 
  • Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction. 
  • Relation between pressure and volume unloading during ramp testing in patients supported with a continuous-flow left ventricular assist device. 
  • Relationship between renal function and left ventricular assist device use. 
  • Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. 
  • Replacement of continuous-flow left ventricular assist device via left subcostal incision. 
  • Reply: Is Pump the Answer to Heart Failure With Preserved Ejection Fraction? 
  • Resource utilization and hospital readmission associated with gastrointestinal bleeding in patients with continuous-flow left ventricular assist devices. 
  • Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). 
  • Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report. 
  • Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. 
  • Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis. 
  • Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. 
  • Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. 
  • Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. 
  • Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial. 
  • Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. 
  • Risk factors for stroke on left ventricular assist devices. 
  • Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. 
  • Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. 
  • Rotary pumps: new developments and future perspectives. 
  • Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study. 
  • Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. 
  • Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers. 
  • Social Support Moderates the Relationship Between Perceived Stress and Quality of Life in Patients With a Left Ventricular Assist Device. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. 
  • Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. 
  • Successful organ donation after long-term circulatory support with nonpulsatile mechanical support. 
  • Surgical Technique for Replacement of Centrifugal Left Ventricular Assist Device Through a Left Thoracotomy. 
  • Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. 
  • Surgical management of Novacor drive-line exit site infections. 
  • Surgical treatments for advanced heart failure. 
  • Survival After Orthotopic Heart Transplantation in Patients Undergoing Bridge to Transplantation With the HeartWare HVAD Versus the Heartmate II. 
  • Temporal changes in hospital costs for left ventricular assist device implantation. 
  • Temporary extracorporeal left ventricular assist device support for implantable left ventricular assist device replacement cases. 
  • The 2018 ISHLT/APM/AST/ICCAC/STSW Recommendations for the Psychosocial Evaluation of Adult Cardiothoracic Transplant Candidates and Candidates for Long-term Mechanical Circulatory Support. 
  • The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. 
  • The ABCs of managing systolic heart failure: Past, present, and future. 
  • The Diagnostic Yield of Repeated Endoscopic Evaluation in Patients with Gastrointestinal Bleeding and Left Ventricular Assist Devices. 
  • The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. 
  • The Risk of Stroke on Left Ventricular Assist Device Support: Steady Gains or Stalled Progress? 
  • The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants. 
  • The bispectral index in the diagnosis of perioperative stroke: a case report and discussion. 
  • The cVAD registry for percutaneous temporary hemodynamic support: A prospective registry of Impella mechanical circulatory support use in high-risk PCI, cardiogenic shock, and decompensated heart failure. 
  • The changing landscape of advanced heart failure therapeutics. 
  • The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. 
  • The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device. 
  • The role of heart failure pharmacotherapy after left ventricular assist device support. 
  • The spectrum of complications following left ventricular assist device placement. 
  • The year in cardiovascular surgery. 
  • Thoratec VAD system as a bridge to heart transplantation. 
  • Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. 
  • Thrombus around the redesigned HeartWare HVAD inflow cannula: A pathologic case series. 
  • Thrombus on the inflow cannula of the HeartWare HVAD: an update. 
  • Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. 
  • Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011. 
  • Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. 
  • Unexpected abrupt increase in left ventricular assist device thrombosis. 
  • Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS. 
  • Use of HeartWare Ventricular Assist System for systemic ventricular support of a pediatric patient after Mustard procedure. 
  • Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart. 
  • Use of a continuous-flow device in patients awaiting heart transplantation. 
  • Usefulness of 2 centrifugal ventricular assist devices in a total artificial heart configuration: A preliminary report. 
  • Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices. 
  • Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. 
  • VA-ECMO for cardiogenic shock in the contemporary era of heart transplantation: Which patients should be urgently transplanted? 
  • Valvular heart disease in patients supported with left ventricular assist devices. 
  • Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes. 
  • Ventricular assist devices and increased blood product utilization for cardiac transplantation. 
  • Warfarin and Aspirin Versus Warfarin Alone for Prevention of Embolic Events in Patients with a HeartMate II Left Ventricular Assist Device. 
  • When VAD Things Happen to Good People. 
  • When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. 
  • Who is a candidate for a left ventricular assist device? Everyone? 
  • Who wants a left ventricular assist device for ambulatory heart failure? Early insights from the MEDAMACS screening pilot. 
  • Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. 
  • Worldwide Experience of a Durable Centrifugal Flow Pump in Pediatric Patients. 
  • iPhone in the Management of the Berlin Heart EXCOR Ventricular Assist Device. 
  • von Willebrand Factor Abnormalities and Heyde Syndrome in Dysfunctional Heart Valve Prostheses. 
• 

  Keywords of People

  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Distinguished Professor of Cardiology, Medicine, Clinical Pharmacology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic